Raymond James Reiterates Passage (PASG) at Outperform, Encouraged to See GM1 Readout, See Significant Upside in the Stock
Tweet Send to a Friend
Raymond James analyst Danielle Brill reiterated an Outperform rating on Passage Bio Inc. (NASDAQ: PASG) following recently reported functional data ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
